U.S. Food and Drug Administration (FDA) Archives - Express Pharma

Biocon Biologics signs US settlement with Regeneron to Launch Yesafili Biosimilar by 2026

Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE

Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no observations

Granules India acquires Senn Chemicals AG to expand peptide therapeutics and CDMO capabilities

Lupin receives tentative FDA approval for generic Darunavir combination tablets

FDA accepts Eisai’s BLA for LEQEMBI subcutaneous autoinjector for alzheimer’s disease treatment

Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat